Nurse Practitioner · Matthews, NC
NPI
1215485867
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
9600 E Independence Blvd
Matthews, NC, 28105
Phone (704) 316-4846
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
2,917 services
Medicare patients, 2024
192
Average age 73
Drug cost, 2024
$1.1M
3,454 prescriptions
Company payments, 2025
$54K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ayeshia I Wright was code J2919 (injection, methylprednisolone sodium succinate, 5 mg), 2,004 times for 33 patients. In total Ayeshia I Wright billed 2,917 services in 24 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,004 | 33 | $0.23 | $454 |
| 99215 Office E&M - Established | Office | 265 | 137 | $105.44 | $28K |
| 99214 Office E&M - Established | Office | 162 | 108 | $74.40 | $12K |
| 96372 Injection Administration | Office | 104 | 38 | $8.90 | $926 |
| 94618 Pulmonary Function Testing | Office | 62 | 57 | $19.46 | $1,207 |
| 96127 Behavioral Health Services | Office | 19 | 19 | $2.42 | $46.04 |
| 99213 Office E&M - Established | Office | 16 | 15 | $57.63 | $922 |
| 99205 Office E&M - New | Office | 15 | 15 | $114.16 | $1,712 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $10.49 | $157 |
By year: 2022 $47K for 762 services; 2023 $43K for 673 services; 2024 $52K for 2,917 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ayeshia I Wright prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 694 prescriptions and refills. In total Ayeshia I Wright wrote 3,454 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 694 | 804 | 186 | $510K |
| Prednisone Generic | 413 | 430 | 214 | $835 |
| Azithromycin Generic | 264 | 280 | 150 | $1,532 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 260 | 300 | 110 | $7,076 |
| Famotidine Generic | 242 | 501 | 108 | $2,504 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 139 | 139 | 112 | $1,087 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 137 | 158 | 42 | $93K |
| Levocetirizine Dihydrochloride Generic | 136 | 308 | 52 | $1,695 |
| Montelukast Sodium Generic | 93 | 185 | 34 | $754 |
| Fluticasone Propionate Generic | 90 | 180 | 45 | $1,094 |
| Fluconazole Generic | 83 | 83 | 64 | $486 |
| Breo Ellipta Fluticasone/Vilanterol | 68 | 84 | 18 | $33K |
| Omeprazole Generic | 50 | 126 | 17 | $651 |
| Azelastine Hcl Generic | 50 | 94 | 20 | $1,651 |
| Clindamycin Hcl Generic | 47 | 47 | 37 | $606 |
Brand drugs: 1,365 claims; generic drugs: 2,089 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ayeshia I Wright $54K ($54K in general payments such as food, travel and fees) from 15 companies. The largest payer was Genzyme Corporation with $39K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 61 | $39K |
| Regeneron Healthcare Solutions, Inc. REGN | 22 | $12K |
| GlaxoSmithKline, LLC. GSK | 25 | $2,205 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $374 |
| Amgen Inc. AMGN | 11 | $142 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $75.64 |
| Insmed, Inc. INSM | 3 | $63.7 |
| Lilly USA, LLC LLY | 3 | $60.89 |
| Viatris Specialty LLC | 3 | $54.99 |
| Merck Sharp & Dohme LLC MRK | 2 | $43.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.